ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Gori to Return As Head Of Smoking Program; Wisconsin, AACI To Honor Harold Rusch

May 18, 1979

New Understanding of drug Resistance Exciting Revolution

September 17, 1982

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

With Fighter Planes Overhead, ODAC Kept Deliberating.

September 21, 2001

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

NCI Appropriations Still Hung Up

September 30, 1977